Results 81 to 90 of about 16,243 (160)

Thoracic Ultrasonography Findings and Their Association With Respiratory Pathogens in 221 Young Beef Cattle at Fattening Farms: A Cross‐Sectional Study

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Thoracic ultrasonography (TUS) could improve antibiotic treatment selection in cattle with respiratory diseases. Hypothesis/Objectives Evaluate the association between respiratory pathogens and consolidations on TUS in feedlot cattle, at both individual and group levels. Animals A total of 221 bulls, aged 8.8 months and weighing 322.
Maud Rouault   +3 more
wiley   +1 more source

Respiratory syncytial virus preventives for children in Australia: current landscape and future directions

open access: yesMedical Journal of Australia, Volume 222, Issue 11, Page 579-586, June 2025.
Summary Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infections, and a leading cause of hospitalisation in children under 6 months of age. Previously, palivizumab, a costly, short‐acting monoclonal antibody, was the primary preventive option.
Sam T Barnett   +4 more
wiley   +1 more source

Development of a New AMBER Force Field for Cysteine and Histidine Cadmium‐Binding Proteins and Its Validation Through QM/MM MD Simulations

open access: yesJournal of Computational Chemistry, Volume 46, Issue 16, June 15, 2025.
In the context of the AMBER parameterization, a new force field is developed and validated for the simulation of cadmium(II)‐binding proteins. The proposed force field takes into account the polarization effect produced by the central ion on its surroundings.
Matteo Orlandi   +5 more
wiley   +1 more source

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus [PDF]

open access: bronze, 1986
Gregory A. Prince   +6 more
openalex   +1 more source

ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, Volume 12, Issue 6, Page 1162-1170, June 2025.
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib   +16 more
wiley   +1 more source

Rational Design of Unsaturated, Thioether Ionizable Lipids for Enhanced In Vivo mRNA Delivery

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 15, 10 June, 2025.
Lipid nanoparticles (LNPs) have rapidly become the delivery system of choice for RNA therapeutics. Here, a rational design approach is taken to improve the effectiveness of LNPs based on an ionizable thioether lipid library. The incorporation of unsaturated tails and bulkier, hydrophobic head groups significantly enhances their functionality and ...
Eleni Samaridou   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy